As anticipated, Evaxion has received a delisting determinationThe determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with ...

As anticipated, Evaxion has received a delisting determinationThe determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with Nas ...

Vaxart ( (VXRT) ) has released its Q3 earnings. Here is a breakdown of the information Vaxart presented to its investors. Vaxart, Inc. is a ...

The Republican Party secured control of the House, giving the G.O.P. a governing trifecta in Washington to enact Mr. Trump’s ...

We're committed to driving innovation to further differentiate our technologies and to bolster our pipeline and we're excited ...

LAS VEGAS, Nov. 13, 2024 /PRNewswire/ -- DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive ... and initiation of a first-in-human (FIH) Phase I study is imminent.

Q3 2024 Earnings Call Transcript November 12, 2024 NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.19, ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

The company remains on track to nominate one to two development candidates in 2025. Technology Platform Updates Using PAM interacting domain engineering, Metagenomi’s ABE platform is able to target ...

We'll face pressure on trade, taxes, defence, energy and climate change and our relations with other countries. Best to start ...

Based on these trends, it is clear that there remains robust demand for a COVID vaccine and we ... It is one of our three pipeline programs with a multibillion dollar market and we are determined to ...